HELPING THE OTHERS REALIZE THE ADVANTAGES OF LDN-27219 AS A CANCER DRUG CANDIDATE

A single especially fascinating compound is LDN-27219. Even though most tTG inhibitors are created to bind towards the protein crosslinking Lively internet site, LDN-27219 alternatively binds towards the nucleotide binding pocket of the enzyme though it can be in its closed-condition conformation, and stabilizes that conformation to prevent crossli